Pure Global

SPRAVATO 28 MG NASAL SPRAY, SOLUTION, 2 PCS - Turkey License f856bf485eac13778c5727849537d0f2

Access comprehensive regulatory information for SPRAVATO 28 MG NASAL SPRAY, SOLUTION, 2 PCS in Turkey's pharmaceutical market through Pure Global AI's free database. This pharmaceutical product is licensed under Turkey number f856bf485eac13778c5727849537d0f2 with license number 2022/103and contains active ingredient Esketamine hydrochloride. The license is held by JOHNSON AND JOHNSON SIHHİ MAL. SAN. VE TİC. LTD. ŞTİ..

This page provides complete pharmaceutical specifications, regulatory compliance details. Pure Global AI offers free access to 21,000+ Turkish pharmaceutical product licenses, helping global pharma companies navigate Turkey SFDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
21,000+ Products
f856bf485eac13778c5727849537d0f2
License Details
Turkey SFDA License: f856bf485eac13778c5727849537d0f2
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Product Details

SPRAVATO 28 MG NASAL SPRAY, SOLUTION, 2 PCS
TR: SPRAVATO 28 MG BURUN SPREYİ, ÇÖZELTİ, 2 ADET
Pharmaceutical Product

License Details

f856bf485eac13778c5727849537d0f2

2022/103

8699593540028

N06AX27

License Holder Information

Active Ingredient

Esketamine hydrochloride

License Information

Mar 07, 2022